Bunker Kevin D.
CIK 0001807484 Name as filed on the most recent filing
Filed as Bunker Kevin D. (36)
114 transaction lines · from 36 filings · filed 2020-11-25 to 2023-10-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
114 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-10-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,085 disposed | 19.43 | 98,783.75 | Form 4, filing 0001725160-23-000180 | |
| 2023-10-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 983 disposed | 19.91 | 19,571.73 | Form 4, filing 0001725160-23-000180 | |
| 2023-05-26 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 80,000 disposed | 30.02 | 2,401,248.00 | Form 4, filing 0001725160-23-000124 | |
| 2023-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 6,500 disposed | 19.98 | 129,873.25 | Form 4, filing 0001725160-23-000031 | |
| 2023-02-13 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,807 disposed | 20.42 | 77,755.69 | Form 4, filing 0001725160-23-000031 | |
| 2022-08-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,000 disposed | 30.00 | 150,000.00 | Form 4, filing 0001725160-22-000159 | |
| 2022-07-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,000 disposed | 30.00 | 150,000.00 | Form 4, filing 0001725160-22-000135 | |
| 2022-07-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,290 disposed | 30.01 | 98,721.06 | Form 4, filing 0001725160-22-000133 | |
| 2022-07-13 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,710 disposed | 30.02 | 51,341.04 | Form 4, filing 0001725160-22-000133 | |
| 2022-07-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 25,000 disposed | 30.07 | 751,652.50 | Form 4, filing 0001725160-22-000131 | |
| 2022-04-11 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,600 disposed | 30.37 | 139,708.90 | Form 4, filing 0001725160-22-000078 | |
| 2022-04-11 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 300 disposed | 32.40 | 9,720.00 | Form 4, filing 0001725160-22-000078 | |
| 2022-04-11 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 100 disposed | 33.16 | 3,316.00 | Form 4, filing 0001725160-22-000078 | |
| 2022-03-21 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,556 disposed | 48.72 | 270,679.43 | Form 4, filing 0001725160-22-000063 | |
| 2022-03-21 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,444 disposed | 49.50 | 219,990.44 | Form 4, filing 0001725160-22-000063 | |
| 2022-03-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,301 disposed | 47.18 | 202,900.97 | Form 4, filing 0001725160-22-000059 | |
| 2022-03-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,000 disposed | 46.23 | 184,935.20 | Form 4, filing 0001725160-22-000059 | |
| 2022-03-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,699 disposed | 47.99 | 81,538.07 | Form 4, filing 0001725160-22-000059 | |
| 2022-02-22 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 6,343 disposed | 48.95 | 310,462.58 | Form 4, filing 0001725160-22-000048 | |
| 2022-02-22 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,451 disposed | 49.92 | 122,350.73 | Form 4, filing 0001725160-22-000048 | |
| 2022-02-22 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 800 disposed | 47.08 | 37,662.80 | Form 4, filing 0001725160-22-000048 | |
| 2022-02-22 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 406 disposed | 50.39 | 20,457.20 | Form 4, filing 0001725160-22-000048 | |
| 2022-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,863 disposed | 50.29 | 143,970.25 | Form 4, filing 0001725160-22-000036 | |
| 2022-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,622 disposed | 50.16 | 81,366.33 | Form 4, filing 0001725160-22-000036 | |
| 2022-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 203 disposed | 50.75 | 10,301.68 | Form 4, filing 0001725160-22-000036 | |
| 2022-02-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,321 disposed | 54.20 | 180,002.52 | Form 4, filing 0001725160-22-000036 | |
| 2022-02-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,074 disposed | 53.19 | 163,501.76 | Form 4, filing 0001725160-22-000036 | |
| 2022-02-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,366 disposed | 52.15 | 123,393.76 | Form 4, filing 0001725160-22-000036 | |
| 2022-02-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,239 disposed | 54.96 | 68,096.93 | Form 4, filing 0001725160-22-000036 | |
| 2022-01-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 6,537 disposed | 60.20 | 393,505.17 | Form 4, filing 0001725160-22-000014 | |
| 2022-01-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,753 disposed | 59.17 | 162,888.68 | Form 4, filing 0001725160-22-000014 | |
| 2022-01-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 710 disposed | 61.29 | 43,518.10 | Form 4, filing 0001725160-22-000014 | |
| 2022-01-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,146 disposed | 67.24 | 211,528.23 | Form 4, filing 0001725160-22-000009 | |
| 2022-01-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,807 disposed | 68.05 | 191,012.70 | Form 4, filing 0001725160-22-000009 | |
| 2022-01-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,212 disposed | 70.02 | 154,893.09 | Form 4, filing 0001725160-22-000009 | |
| 2022-01-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,835 disposed | 69.03 | 126,663.08 | Form 4, filing 0001725160-22-000009 | |
| 2021-12-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,889 disposed | 79.78 | 310,266.36 | Form 4, filing 0001725160-21-000244 | |
| 2021-12-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,161 disposed | 77.45 | 167,369.67 | Form 4, filing 0001725160-21-000244 | |
| 2021-12-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,071 disposed | 80.76 | 167,253.13 | Form 4, filing 0001725160-21-000244 | |
| 2021-12-20 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,879 disposed | 78.52 | 147,541.52 | Form 4, filing 0001725160-21-000244 | |
| 2021-12-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,117 disposed | 72.10 | 368,950.54 | Form 4, filing 0001725160-21-000238 | |
| 2021-12-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,049 disposed | 71.17 | 288,150.73 | Form 4, filing 0001725160-21-000238 | |
| 2021-12-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 434 disposed | 70.29 | 30,504.99 | Form 4, filing 0001725160-21-000238 | |
| 2021-12-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 400 disposed | 73.75 | 29,500.00 | Form 4, filing 0001725160-21-000238 | |
| 2021-11-22 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 10,000 disposed | 75.99 | 759,937.00 | Form 4, filing 0001725160-21-000228 | |
| 2021-11-10 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 10,000 disposed | 78.15 | 781,471.00 | Form 4, filing 0001725160-21-000222 | |
| 2021-10-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,679 disposed | 66.89 | 246,075.43 | Form 4, filing 0001725160-21-000200 | |
| 2021-10-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,121 disposed | 65.80 | 205,362.42 | Form 4, filing 0001725160-21-000200 | |
| 2021-10-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,416 disposed | 64.73 | 91,658.95 | Form 4, filing 0001725160-21-000200 | |
| 2021-10-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 204 disposed | 67.44 | 13,758.76 | Form 4, filing 0001725160-21-000200 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 113
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Bunker Kevin D., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001807484
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6